Regional and intralesional treatment of invasive basal cell carcinoma with interferon alfa-n2b.
DiLorenzo
P A
PA
Department of Internal Medicine, Provident St. Anthony Hospital, Wheat Ridge, CO 80033.
Goodman
N
N
Lansville
F
F
Markel
W
W
D000368:Aged; D002280:Basal Cell Carcinoma / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D009918:Orbital Neoplasms / Q000175:diagnosis / Q000628:therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins